MEDICAMENTS

Plus

    UK – NICE U-turn for Kisqali in breast cancer

    The decision comes just three months after the governing body issued a draft guidance rejecting the drug, citing that “it is not known whether...

    DISPOSITIFS MEDICAUX

    Plus

      COSMETIQUES

      Plus

        Europe – SCCS – Final Opinion on Solubility of Synthetic Amorphous...

        The SCCS concludes the following: 1. Does the SCCS consider that Synthetic Amorphous Silica (SAS) are soluble (100 mg/L or higher) or degradable/non-persistent in biological systems,...

        SANTE PUBLIQUE

        Plus

          INSCRIVEZ-VOUS A NOTRE NEWSLETTER

          NOS PROCHAINES FORMATIONS